Exhibit A

JOINT FILING AGREEMENT

The undersigned agree that this Amendment No. 28 to Schedule 13D, dated January 28, 2025, relating to the Common Shares, no par value, of Lineage Cell Therapeutics, Inc. shall be filed on behalf of the undersigned.

 

Dated:  January 28, 2025

Broadwood Partners, L.P.

 

  By: Broadwood Capital, Inc.
   
  By: /s/ Neal C. Bradsher
  Name: Neal C. Bradsher
  Title: President
     
   

 

 

  Broadwood Capital, Inc.
   
  By: /s/ Neal C. Bradsher
  Name: Neal C. Bradsher
  Title: President
   

 

 

     
  /s/ Neal C. Bradsher
  Neal C. Bradsher

 

 

 

 

 

Lineage Cell Therapeutics (AMEX:LCTX)
Graphique Historique de l'Action
De Fév 2025 à Mar 2025 Plus de graphiques de la Bourse Lineage Cell Therapeutics
Lineage Cell Therapeutics (AMEX:LCTX)
Graphique Historique de l'Action
De Mar 2024 à Mar 2025 Plus de graphiques de la Bourse Lineage Cell Therapeutics